BioCentury
ARTICLE | Company News

Medicines Co. gets approvable letter

May 17, 2000 7:00 AM UTC

The Medicines Co. ( Cambridge, Mass.) received an approvable letter from the FDA for its Angiomax bivalirudin anticoagulant thrombin inhibitor to treat patients with unstable angina undergoing angioplasty. Angiomax is approved for marketing in New Zealand. ...